Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q3 2017 · 10-Q
Revenue$172.05K$172.05K+6.0% vs Q3 2016 Net Income-$2.25M-$2.25MN/M vs Q3 2016 EPS Diluted-$0.02-$0.02N/M vs Q3 2016 Gross Profit$48,767−57.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,026,017N/M Margins · derivedGross margin28.3%−42.6 pt vs Q3 2016
Operating margin-872.6%−117.6 pt vs Q3 2016
Net margin-1305.5%+224.8 pt vs Q3 2016
ended Sep 30, 2017 · filed Nov 14, 2017 · 45 d after period end